a social network from News-Medical.Net
GTC is proud to announce its inaugural Orphan Drugs Research and Commercialization Conference at a crucial time in the rare disease space. With new therapies emerging in rare disease treatment and exciting partnerships being forged between big pharma and smaller niche companies, it is clear that the field of rare disease and orphan drug is growing. Rather than merely reciting the challenges of orphan drug development, it is time all stakeholders in the community come together to find innovative solutions in order to better serve rare disease patients.
Conference Date: May 08-10, 2013
Venue: Hyatt Regency, 1 Ave De Lafayette, Boston, Massachusetts
Event Link: http://www.gtcbio.com/component/conference/?file=home&cn=Orphan+Drugs+Research+and+Commercialization&cid=114&utm_source=ConfWebsite&utm_medium=Posting&utm_campaign=OrphanPost